<DOC>
	<DOCNO>NCT00051506</DOCNO>
	<brief_summary>The purpose study evaluate effect ( good bad ) ALIMTA plus Carboplatin ALIMTA plus Cisplatin small cell lung cancer .</brief_summary>
	<brief_title>ALIMTA ( Pemetrexed ) /Cisplatin ALIMTA ( Pemetrexed ) /Carboplatin Extensive Stage Small Cell Lung Cancer .</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Have diagnosis extensive stage small cell lung cancer treat chemotherapy . Have receive prior chemotherapy disease . Have least one measurable lesion . adequate performance status . Sign inform consent form . Have previously receive chemotherapy lung cancer . Have treat investigational drug within last 30 day . Have previously complete withdrawn study study investigate ALIMTA . Have receive radiation therapy within last 12 week . Have brain metastasis uncontrolled . Have active infection serious condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
</DOC>